ScandiDos AB (SDOS) - Net Assets

Latest as of April 2026: Skr41.66 Million SEK ≈ $4.48 Million USD

Based on the latest financial reports, ScandiDos AB (SDOS) has net assets worth Skr41.66 Million SEK (≈ $4.48 Million USD) as of April 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr65.97 Million ≈ $7.10 Million USD) and total liabilities (Skr24.31 Million ≈ $2.62 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check strategic asset allocation of ScandiDos AB to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric Value
Current Net Assets Skr41.66 Million
% of Total Assets 63.15%
Annual Growth Rate 8.62%
5-Year Change 12.0%
10-Year Change -5.32%
Growth Volatility 77.62

ScandiDos AB - Net Assets Trend (2011–2026)

This chart illustrates how ScandiDos AB's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see ScandiDos AB (SDOS) total market value.

Annual Net Assets for ScandiDos AB (2011–2026)

The table below shows the annual net assets of ScandiDos AB from 2011 to 2026. Also explore SDOS net asset momentum to track the company's year-over-year net asset growth rate.

Year Net Assets Change
2026-04-30 Skr41.66 Million
≈ $4.48 Million
-7.38%
2025-04-30 Skr44.98 Million
≈ $4.84 Million
+1.56%
2024-04-30 Skr44.29 Million
≈ $4.77 Million
+6.32%
2023-04-30 Skr41.65 Million
≈ $4.48 Million
+11.98%
2022-04-30 Skr37.20 Million
≈ $4.00 Million
-17.67%
2021-04-30 Skr45.18 Million
≈ $4.86 Million
-2.33%
2020-04-30 Skr46.26 Million
≈ $4.98 Million
+61.64%
2019-04-30 Skr28.62 Million
≈ $3.08 Million
-38.56%
2018-04-30 Skr46.58 Million
≈ $5.01 Million
+5.85%
2017-04-30 Skr44.00 Million
≈ $4.74 Million
+37.51%
2016-04-30 Skr32.00 Million
≈ $3.44 Million
+26.26%
2015-04-30 Skr25.34 Million
≈ $2.73 Million
-37.40%
2014-04-30 Skr40.48 Million
≈ $4.36 Million
+296.54%
2013-04-30 Skr10.21 Million
≈ $1.10 Million
-17.11%
2012-04-30 Skr12.32 Million
≈ $1.33 Million
+2.23%
2011-04-30 Skr12.05 Million
≈ $1.30 Million
--

Equity Component Analysis

This analysis shows how different components contribute to ScandiDos AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 52828.3% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (April 2026)

Component Amount Percentage
Common Stock Skr2.85 Million 6.84%
Other Components Skr208.07 Million 499.42%
Total Equity Skr41.66 Million 100.00%

ScandiDos AB Competitors by Market Cap

The table below lists competitors of ScandiDos AB ranked by their market capitalization.

Company Market Cap
Creative Global Technology Holdings Limited Ordinary Shares
NASDAQ:CGTL
$4.29 Million
Vision Marine Technologies Inc
NASDAQ:VMAR
$4.30 Million
Era Mandiri Cemerlang Tbk PT
JK:IKAN
$4.30 Million
Pacte Novation
PA:MLPAC
$4.30 Million
Accelerate Resources Ltd
AU:AX8
$4.29 Million
BrenX Ltd.
NASDAQ:BRNX
$4.29 Million
Project Planning Service Public Company Limited
BK:PPS
$4.29 Million
Strategem Capital Corp
V:SGE
$4.29 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in ScandiDos AB's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2025 to 2026, total equity changed from 44,980,000 to 41,662,000, a change of -3,318,000 (-7.4%).
  • Net loss of 3,435,000 reduced equity.

Equity Change Factors (2025 to 2026)

Factor Impact Contribution
Net Income Skr-3.44 Million -8.24%
Other Changes Skr117.00K +0.28%
Total Change Skr- -7.38%

Book Value vs Market Value Analysis

This analysis compares ScandiDos AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.96x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has increased from 0.13x to 0.96x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2011-04-30 Skr5.57 Skr0.70 x
2012-04-30 Skr5.69 Skr0.70 x
2013-04-30 Skr4.72 Skr0.70 x
2014-04-30 Skr2.78 Skr0.70 x
2015-04-30 Skr1.86 Skr0.70 x
2016-04-30 Skr1.68 Skr0.70 x
2017-04-30 Skr1.66 Skr0.70 x
2018-04-30 Skr1.54 Skr0.70 x
2019-04-30 Skr0.99 Skr0.70 x
2020-04-30 Skr1.12 Skr0.70 x
2021-04-30 Skr1.09 Skr0.70 x
2022-04-30 Skr0.90 Skr0.70 x
2023-04-30 Skr0.91 Skr0.70 x
2024-04-30 Skr0.97 Skr0.70 x
2025-04-30 Skr0.99 Skr0.70 x
2026-04-30 Skr0.73 Skr0.70 x

Capital Efficiency Dashboard

This dashboard shows how efficiently ScandiDos AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -8.24%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -6.34%
  • • Asset Turnover: 0.82x
  • • Equity Multiplier: 1.58x
  • Recent ROE (-8.24%) is above the historical average (-24.54%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2011 2.66% 1.11% 1.49x 1.62x Skr-883.80K
2012 1.84% 0.63% 1.47x 1.98x Skr-1.00 Million
2013 -20.50% -5.25% 1.35x 2.88x Skr-3.11 Million
2014 -10.37% -10.85% 0.72x 1.33x Skr-8.25 Million
2015 -57.94% -44.60% 0.76x 1.71x Skr-17.22 Million
2016 -44.51% -42.42% 0.58x 1.80x Skr-17.44 Million
2017 -29.90% -27.75% 0.75x 1.44x Skr-17.56 Million
2018 -24.83% -22.87% 0.76x 1.42x Skr-16.22 Million
2019 -62.06% -36.38% 0.71x 2.42x Skr-20.62 Million
2020 -28.39% -22.93% 0.81x 1.53x Skr-17.76 Million
2021 -3.10% -2.33% 0.78x 1.71x Skr-5.92 Million
2022 -19.73% -12.72% 0.87x 1.78x Skr-11.06 Million
2023 -21.89% -14.82% 0.85x 1.74x Skr-13.28 Million
2024 -33.07% -24.24% 0.74x 1.84x Skr-19.08 Million
2025 -32.56% -24.24% 0.82x 1.63x Skr-19.14 Million
2026 -8.24% -6.34% 0.82x 1.58x Skr-7.60 Million

Industry Comparison

This section compares ScandiDos AB's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $773,085,954
  • Average return on equity (ROE) among peers: -68.53%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
ScandiDos AB (SDOS) Skr41.66 Million 2.66% 0.58x $4.29 Million
Acarix A/S (ACARIX) $38.17 Million -125.99% 0.27x $26.71 Million
Arcoma AB (ARCOMA) $40.83 Million -24.05% 0.67x $11.70 Million
Bactiguard Holding AB (publ) (BACTI-B) $386.69 Million 4.20% 0.66x $51.95 Million
BICO Group AB (BICO) $6.80 Billion -3.37% 0.43x $165.40 Million
Boule Diagnostics AB (BOUL) $169.99 Million 17.80% 0.65x $10.41 Million
CellaVision AB (CEVI) $183.52 Million 28.78% 0.20x $418.90 Million
Clinical Laserthermia Systems AB (publ) (CLS-B) $43.53 Million -183.31% 0.33x $9.40 Million
Chordate Medical Holding AB (CMH) $29.55 Million -46.39% 0.39x $29.05K
C-Rad AB (publ) (CRAD-B) $29.82 Million -34.38% 0.50x $119.27 Million
Duearity AB (DEAR) $6.06 Million -318.56% 0.99x $331.97K

About ScandiDos AB

ST:SDOS Sweden Medical Devices
Market Cap
$4.29 Million
Skr39.91 Million SEK
Market Cap Rank
#28969 Global
#654 in Sweden
Share Price
Skr0.70
Change (1 day)
-2.78%
52-Week Range
Skr0.70 - Skr1.20
All Time High
Skr11.20
About

ScandiDos AB (publ), together with its subsidiaries, provides measurement phantoms and software solutions for the quality assurance and validation of dynamic and modulated treatments adopted in clinics in the United States, Europe, Asia, and internationally. The company offers Delta4 products comprising Delta4 Phantom+, Delta4Phantom+MR, Delta4 HexaMotion, Delta4Insight, Delta4DVH Anatomy, Delta4… Read more